Therapy for fetal supraventricular tachycardia with a combination of flecainide and digoxin;Kombinationstherapie einer fetalen supraventrikulären tachykardie mit flecainid und digoxin

Zeitschrift fur Geburtshilfe und Neonatologie

Volumn 209, Issue 1, 2005, Pages 34-37

  Anderer, Georgia ^a   Hellmeyer, L ^a   Tekesin, I ^a   Schmidt, S ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Fetal supraventricular tachycardia; Non immunologic hydrops fetalis

Indexed keywords

ACETYLDIGOXIN; FLECAINIDE;

ARTICLE; ASCITES; CARDIOVERSION; CASE REPORT; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; FETUS; FETUS DISEASE; FETUS ECHOGRAPHY; FETUS HEART RATE; FETUS HYDROPS; GESTATIONAL AGE; HUMAN; PERICARDIAL EFFUSION; PLEURA EFFUSION; SUPRAVENTRICULAR TACHYCARDIA; SYMPTOM; TREATMENT OUTCOME; TRICUSPID VALVE REGURGITATION;

ADULT; ANTI-ARRHYTHMIA AGENTS; DIGOXIN; DRUG COMBINATIONS; FEMALE; FETAL DISTRESS; FLECAINIDE; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, THIRD; TACHYCARDIA, SUPRAVENTRICULAR; TREATMENT OUTCOME;

EID: 14944351087     PISSN: 09482393     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-837798     Document Type: Article

References (25)

1. Holzgreve W, Gembruch U, Hentschel R, Tercanli S. Nichtimmunologischer Hydrops fetalis. Ultraschall in Gynäkologie und Geburtshilfe. Herausgeber Sohn C, Tercanli S, Holzgreve W. Thieme, 2003; 2. Auflage: 399-404
2. Naheed ZJ, Strasburger JF, Deal BJ, Benson DW, Gidding SS. Fetal tachycardia: mechanisms and predictors of hydrops fetalis. J Am Coll Cardiol 1996; 27: 1736-40
3. Gembruch U, Krapp M, Baumann P. Changes of venous blood flow velocity waveforms in fetuses with supraventricular tachycardia. Ultrasound Obstet Gynecol 1995; 5: 394-9
4. Kleinman CS, Copel JA, Weinstein EM, Santulli RV, Hobbins JC. In utero treatment of fetal supraventicular tachycardia. Semin Perinatol 1985; 9: 113-29
5. Gembruch U, Redel DA, Bald R, Hansmann M. Longitudinal study in 18 cases of fetal supraventricular tachycardia: Dopplerechocardiographic findings and pathophysiological implications. Am Heart J 1993; 125: 1290-301
6. Maxwell DJ, Crawford DC, Curry PVM, Tynan MJ, Allan LD. Obstetric importance, diagnosis, and management of fetal tachycardias. BMJ 1988; 297: 107-10
7. Hansmann M, Gembruch U, Bald R, Manz M, Redel DA. Fetal tachyarrhythmias: transplacental and direct treatment of the fetus, a report of sixty fetuses. Ultrasound Obstet Gynecol 1991; 1: 162-70
8. Simpson JM, Sharland GK. Fetal tachycardias: management and outcome of 127 consecutive cases. Heart 1998; 79: 576-81
9. Kleinman CS, Nehgme R, Copel JA. Fetal cardiac arrhythmias. Diagnosis and therapy. In Creasy RK, Resnik R, eds. Maternal-Fetal Medicine Philadelphia: WB Saunders, 1999: 301-18
10. Simpson J. Fetal arrythmia. In Allan L, Hornberger L, Sharland G, eds. Textbook of Fetal Cardiology London: Greenwich Medical Media, 2000: 423-51
11. Krapp M, Baschat AA, Gembruch U, Geipel A, Germer U. Flecainide in the intrauterine treatment of fetal supraventricular tachycardia. Ultrasound Obstet Gynecol 2002; 19: 158-164
12. Simpson JM, Milburn A, Yates RW, Maxwell DJ, Sharland GK. Outcome of intermittent tachyarrhythmias in the fetus. Pediatr Cardiol 1997 Mar-Apr; 18(2): 78-82
13. Kleinman CS, Copel JA. Electrophysiological principles and fetal anti-arrhythmic therapy. Ultrasound Obstet Gynecol 1991; 1: 286-297
14. Frohn-Mulder IM, Stewart PA, Witsenburg M, Den Hollander NS, Wladimiroff JW, Hess J. The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia. Prenat Diagn 1995; 15: 1209-1213
15. Gembruch U, Manz M, Bald R, Ruddel H, Redel DA, Schlebusch H, Nisch J, Hansmann M. Repeated treatment with amiodarone in a fetus with refractory supraventricular tachycardia and hydrops fetalis. Am Heart J 1989; 118: 1335-1338
16. Hallak M, Neerhof MG, Perry R, Nazir M, Huhta JC. Fetal supraventricular tachycardia and hydrops fetalis: combined intensive, direct, and transplacental therapy. Obstet Gynecol 1991; 78: 523-525
17. Parilla BV, Strasburger JF, Socol ML. Fetal supraventricular tachycardia complicated by hydrops fetalis: a role for direct fetal intramuscular therapy. Am J Perinatol 1996; 13: 483-486
18. Owen J, Colvin EV, Davis RO. Fetal death after successful conversion of fetal supraventricular tachycardia with digoxin and verapamil. Am J Obstet Gynecol 1988; 158: 1169-1170
19. Sonesson SE, Fouron JC, Weeslen-Eriksson E, Jaeggi E, Winberg. Foetal supraventricular tachycardia treated with sotalol. Acta Paediatr 1998; 87: 584-587
20. Oudijk MA, Michon MM, Kleinmann CS, Kapusta L, Stoutenbeek P, Visser GHA, Meijboom EJ. Sotalol in the treatment of fetal dysrhythmias. Circulation 2000; 101: 2721-2726
21. Briggs GG, Freeman R, Yaffe SJ. Propranolol: Drugs in Pregnancy and Lactation, ed E. Baltimore: Lippincott/Williams & Wilkins, 2001: pp 1176-1180
22. Keefe DL, Miura D, Somberg JC. Supraventricular tachyarrhythmias: their evaluation and therapy. Am Heart J 1986; 111: 1150-1161
23. Schwartz A, Shen E, Morady F, Gillespie K, Scheinman M, Chatterjee K. Hemodynamic effects of intravenous amiodarone in patients with depressend left ventricular function and recurrent ventricular tachycardia. Am Heart J 1983; 108: 848-856
24. Rovet J, Ehrlich R, Sobara D. Intellectual outcome in children with fetal hypothyroidism. J Pediatr 1987; 110: 700-704
25. Allan LD, Chita SK, Sharland GK, Maxwell D, Priestly K. Flecainide in the treatment of fetal tachyarrhythmias. Br Heart J 1991; 65: 46-48